Procter & Gamble Analyst Ratings
Johnson & Johnson Analyst Ratings
HSBC Adjusts Price Target on Johnson & Johnson to $174 From $170, Maintains Buy Rating
Deutsche Bank Raises Price Target on UnitedHealth Group to $632 From $562, Keeps Buy Rating
Barclays Sticks to Their Buy Rating for Chevron (CVX)
Barclays Remains a Buy on Procter & Gamble (PG)
Chevron Analyst Ratings
UnitedHealth Group Analyst Ratings
UBS Adjusts UnitedHealth Group Price Target to $680 From $640, Maintains Buy Rating
RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target
Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
Bank of America Analyst Ratings
TD Cowen Adjusts Price Target on Linde to $480 From $455
Evercore ISI Sticks to Its Buy Rating for Procter & Gamble (PG)
Evercore ISI Adjusts Price Target on Procter & Gamble to $183 From $177, Maintains Outperform Rating
Oppenheimer Adjusts Price Target on Bank of America to $49 From $46, Maintains Outperform Rating
Johnson & Johnson (JNJ) Gets a Buy From RBC Capital
Morgan Stanley Adjusts Price Target on Johnson & Johnson to $169 From $167, Maintains Equalweight Rating
Johnson & Johnson Analyst Ratings
UnitedHealth's Strong Q2 Performance and Strategic Initiatives Secure Buy Rating